Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
12,415,462
-
Share change
-
-415,963
-
Total reported value
-
$684,574,836
-
Price per share
-
$55.39
-
Number of holders
-
146
-
Value change
-
-$25,432,656
-
Number of buys
-
72
-
Number of sells
-
58
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q2 2022
As of 30 Jun 2022,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
146 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,415,462 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, MORGAN STANLEY, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, GOLDMAN SACHS GROUP INC, AMERIPRISE FINANCIAL INC, Mondrian Investment Partners LTD, and JPMORGAN CHASE & CO.
This page lists
146
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.